Report from the World Health Organization's immunization and vaccines-related implementation research advisory committee (IVIR-AC) ad hoc meeting, 28 June – 1 July 2024
2024

WHO Report on Rubella Vaccine Introduction

Commentary Evidence: moderate

Author Information

Author(s): Philipp Lambach, Sheetal Silal, Alyssa N. Sbarra, Natasha S. Crowcroft, Kurt Frey, Matt Ferrari, Emilia Vynnycky, C. Jessica E. Metcalf, Amy K. Winter, Laura Zimmerman, Mitsuki Koh, Meru Sheel, Sun-Young Kim, Patrick K. Munywoki, Allison Portnoy, Rakesh Aggarwal, Habib Hasan Farooqui, Stefan Flasche, Alexandra B. Hogan, Kathy Leung, William J. Moss, Xuan-Yi Wang

Primary Institution: World Health Organization

Hypothesis

What are the implications of introducing rubella vaccines on congenital rubella syndrome incidence?

Conclusion

Introducing rubella vaccines can significantly reduce the burden of congenital rubella syndrome if implemented with sufficient coverage and follow-up campaigns.

Supporting Evidence

  • Rubella vaccination can prevent congenital rubella syndrome if implemented with high coverage.
  • Countries without rubella vaccination programs have higher rates of congenital rubella syndrome.
  • Modeling suggests that demographic changes can increase the incidence of congenital rubella syndrome in the absence of vaccination.

Takeaway

This report says that giving rubella vaccines can help stop babies from getting sick from rubella if enough people get vaccinated.

Methodology

The report summarizes findings from modeling analyses presented by various teams regarding rubella vaccination and its impact on congenital rubella syndrome.

Limitations

The report does not provide specific data on the effectiveness of rubella vaccination in all countries, focusing instead on modeling scenarios.

Digital Object Identifier (DOI)

10.1016/j.vaccine.2024.126307

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication